# Nuclide record sofie-biosciences (company). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/companies/sofie-biosciences/>
  a schema:Organization ;
  nuclide:kind "company" ;
  schema:identifier "sofie-biosciences" ;
  schema:name "SOFIE Biosciences"@en ;
  schema:description "SOFIE Biosciences is a US radiopharmacy network running two phase 3 trials of the FAP PET tracer [18F]FAPI-74 in pancreatic and gastro-oesophageal cancer."@en ;
  schema:url <https://nuclide.cc/companies/sofie-biosciences/>, <https://sofie.com> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://sofie.com/2026/02/11/sofie-biosciences-announces-first-patient-dosed-in-18ffapi-74-phase-3-study-for-pancreatic-cancer/> ;
  schema:addressCountry "US" ;
  nuclide:related <https://nuclide.cc/isotopes/f-18/> ;
  nuclide:technologies <https://nuclide.cc/technologies/fapi-pet/>, <https://nuclide.cc/technologies/pet/> ;
  nuclide:targets <https://nuclide.cc/targets/fap/> ;
  nuclide:institutions <https://nuclide.cc/institutions/heidelberg-nct/> ;
  nuclide:trials <https://nuclide.cc/trials/nct07217704/> .